Algeria vs Equatorial Guinea: Share of children with symptoms of a respiratory infection who received antibiotics
Algeria
60.5%
in 2018
Equatorial Guinea
59.9%
in 2018
Algeria rank
35th
Equatorial Guinea rank
37th
Share of children with symptoms of a respiratory infection who received antibiotics over time
- Algeria
- Equatorial Guinea
How they compare
Algeria currently reports 60.5% against 59.9% in Equatorial Guinea, a difference of 0.6%.
The two have swapped places 2 times across 19 shared years of data; in 2000 it was Algeria ahead.
Algeria ranks 35th and Equatorial Guinea ranks 37th of 132 countries.
Algeria has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Algeria | Equatorial Guinea | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 60.1% | 51.4% | 8.8% | Algeria |
| 2010s | 63.0% | 59.8% | 3.2% | Algeria |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of children with symptoms of a respiratory infection who received antibiotics, Algeria or Equatorial Guinea?
- Algeria, at 60.5% against 59.9% in Equatorial Guinea as of 2018.
- What is the difference in share of children with symptoms of a respiratory infection who received antibiotics between Algeria and Equatorial Guinea?
- 0.6%, with Algeria ahead.
- How many years of comparable data are there for Algeria and Equatorial Guinea?
- 19 years are reported by both, from 2000 to 2018.
- How do Algeria and Equatorial Guinea rank globally for share of children with symptoms of a respiratory infection who received antibiotics?
- Algeria ranks 35th and Equatorial Guinea ranks 37th of 132 countries.
- Where does this data come from?
- Browne AJ et al. (2021) – processed by Our World in Data, published as Share of children with symptoms of a respiratory infection who received antibiotics. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Caregiver reported share of children under five years old, with symptoms of lower respiratory tract infection, who received antibiotics for this illness.